SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs informs about credit rating

17 Jul 2025 Evaluate

Aarti Pharmalabs has informed that, CRISIL Ratings has upgraded the credit ratings for long-term bank loan facilities of the Company vide its communication dated 17th July, 2025. The company has enclosed the details of the ratings on the bank facilities. A copy of the report from CRISIL Ratings is also enclosed. The above information will also be available on the website of the Company at https://www.aartipharmalabs.com/credit-ratings.

The above information is a part of company’s filings submitted to BSE. 


Aarti Pharmalabs Share Price

629.45 -14.20 (-2.21%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×